{"id":800112,"date":"2025-01-13T12:05:32","date_gmt":"2025-01-13T17:05:32","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-january-17-2025-to-discuss-your-rights-huma\/"},"modified":"2025-01-13T12:05:32","modified_gmt":"2025-01-13T17:05:32","slug":"humacyte-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-january-17-2025-to-discuss-your-rights-huma","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-january-17-2025-to-discuss-your-rights-huma\/","title":{"rendered":"Humacyte, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact Levi &amp; Korsinsky Before January 17, 2025 to Discuss Your Rights \u2013 HUMA"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW YORK, Jan.  13, 2025  (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in <strong>Humacyte, Inc.<\/strong> (&#8220;Humacyte, Inc.&#8221; or the &#8220;Company&#8221;) (NASDAQ: HUMA) of a class action securities lawsuit.<\/p>\n<p>\n        <strong>CLASS DEFINITION: <\/strong>The lawsuit seeks to recover losses on behalf of Humacyte, Inc. investors who were adversely affected by alleged securities fraud between May 10, 2024 and October 17, 2024. Follow the link below to get more information and be contacted by a member of our team:<\/p>\n<p align=\"center\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WVAtx0o0WhBsMWHFh1ZgYwMfrZrGWlCDkB8jZdEnPDJl1U_NXaNlUBat6bfA1nH3RDih7LtjOEQP0v5hRWmulrttGOpD3zRCD9QWq3PGyoaiyukdIMEHvn_m3kBtv1LMN8W89eIDnvYH1kMnsow879ebX-z1ffQLMdDLTYAv-_7SoGSL9bvLBqi-2vJCnL34FFAQhphFRu1fUxaTBlL5qLh1rj_SOEkxZMQnGECFDR7nc8DjzQ-p1-Ki6ZbDqTrv\" rel=\"nofollow\" target=\"_blank\">https:\/\/zlk.com\/pslra-1\/humacyte-inc-lawsuit-submission-form?prid=122014&amp;wire=3<\/a>\u00a0<\/p>\n<p>\n        <strong>HUMA<\/strong> investors may also contact Joseph E. Levi, Esq. via email at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7MUrMq-H5yqQ-rFgxCte_mD6VTRmKIBheCva0LwOJ3cMn_rqQdMq--sjerL-K1LCgEsm3nfT71GLG_V9j22fMX81yGVuS9GumiPyuleuS7M=\" rel=\"nofollow\" target=\"_blank\">jlevi@levikorsinsky.com<\/a>\u00a0or by telephone at (212) 363-7500.<\/p>\n<p>\n        <strong>CASE DETAILS: <\/strong>The filed complaint alleges that defendants made false statements and\/or concealed that: (1) the Company\u2019s Durham, North Carolina facility failed to comply with good manufacturing practices, including quality assurance and microbial testing; (2) the FDA\u2019s review of the biologics license application would be delayed while Humacyte remediated these deficiencies; and (3) as a result, there was a substantial risk to FDA approval of acellular tissue engineered vessel for vascular trauma; and (4) as a result of the foregoing, Defendants\u2019 positive statements about the Company\u2019s business, operations, and prospects were materially misleading and\/or lacked a reasonable basis.<\/p>\n<p>\n        <strong>WHAT&#8217;S NEXT? <\/strong>If you suffered a loss in Humacyte, Inc. during the relevant time frame, you have until <strong>January 17, 2025<\/strong>\u00a0to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn&#8217;t require that you serve as a lead plaintiff.<\/p>\n<p>\n        <strong>NO COST TO YOU: <\/strong>If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. <strong>There is no cost or obligation to participate.<\/strong><\/p>\n<p>\n        <strong>WHY LEVI &amp; KORSINSKY: <\/strong>Over the past 20 years, the team at Levi &amp; Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi &amp; Korsinsky has ranked in ISS Securities Class Action Services\u2019 Top 50 Report as one of the top securities litigation firms in the United States.<\/p>\n<p>\n        <strong>CONTACT:<\/strong><br \/>\n        <br \/>Levi &amp; Korsinsky, LLP <br \/>Joseph E. Levi, Esq.<br \/>Ed Korsinsky, Esq.<br \/>33 Whitehall Street, 17th Floor<br \/>New York, NY 10004<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7MUrMq-H5yqQ-rFgxCte_mD6VTRmKIBheCva0LwOJ3ecOBO7MBNeyKon9XefPc3H4vtWmZVuCmMo4hfm72aTOAI2NDfY2cgzyOswqoyOGX8=\" rel=\"nofollow\" target=\"_blank\">jlevi@levikorsinsky.com<\/a>\u00a0<br \/>Tel: (212) 363-7500<br \/>Fax: (212) 363-7171<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=R8vAhLZpAVydbV1s1DwcVNHsd4thGQEazo5P8Ir8pEoqRlzQWIpOek7pv35vdd-FxOZjmmkWyO6QMj5nRX0K4Q==\" rel=\"nofollow\" target=\"_blank\">www.zlk.com<\/a>\u00a0<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMzMTEwNCM2NjkxNTczIzIwMjA0MjY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZjhiYTA0MDYtM2E4YS00MmY4LWFkYmUtYTc1NmZhMjdiN2E0LTEwMzIyOTM=\/tiny\/Levi-Korsinsky-LLP.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, Jan. 13, 2025 (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in Humacyte, Inc. (&#8220;Humacyte, Inc.&#8221; or the &#8220;Company&#8221;) (NASDAQ: HUMA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Humacyte, Inc. investors who were adversely affected by alleged securities fraud between May 10, 2024 and October 17, 2024. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/humacyte-inc-lawsuit-submission-form?prid=122014&amp;wire=3\u00a0 HUMA investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and\/or concealed that: (1) the Company\u2019s Durham, North Carolina facility failed to comply with &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-january-17-2025-to-discuss-your-rights-huma\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Humacyte, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact Levi &amp; Korsinsky Before January 17, 2025 to Discuss Your Rights \u2013 HUMA&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-800112","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Humacyte, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact Levi &amp; Korsinsky Before January 17, 2025 to Discuss Your Rights \u2013 HUMA - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-january-17-2025-to-discuss-your-rights-huma\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Humacyte, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact Levi &amp; Korsinsky Before January 17, 2025 to Discuss Your Rights \u2013 HUMA - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Jan. 13, 2025 (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in Humacyte, Inc. (&#8220;Humacyte, Inc.&#8221; or the &#8220;Company&#8221;) (NASDAQ: HUMA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Humacyte, Inc. investors who were adversely affected by alleged securities fraud between May 10, 2024 and October 17, 2024. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/humacyte-inc-lawsuit-submission-form?prid=122014&amp;wire=3\u00a0 HUMA investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and\/or concealed that: (1) the Company\u2019s Durham, North Carolina facility failed to comply with &hellip; Continue reading &quot;Humacyte, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact Levi &amp; Korsinsky Before January 17, 2025 to Discuss Your Rights \u2013 HUMA&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-january-17-2025-to-discuss-your-rights-huma\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-13T17:05:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMzMTEwNCM2NjkxNTczIzIwMjA0MjY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-january-17-2025-to-discuss-your-rights-huma\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-january-17-2025-to-discuss-your-rights-huma\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Humacyte, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact Levi &amp; Korsinsky Before January 17, 2025 to Discuss Your Rights \u2013 HUMA\",\"datePublished\":\"2025-01-13T17:05:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-january-17-2025-to-discuss-your-rights-huma\\\/\"},\"wordCount\":408,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-january-17-2025-to-discuss-your-rights-huma\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMzMTEwNCM2NjkxNTczIzIwMjA0MjY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-january-17-2025-to-discuss-your-rights-huma\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-january-17-2025-to-discuss-your-rights-huma\\\/\",\"name\":\"Humacyte, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact Levi &amp; Korsinsky Before January 17, 2025 to Discuss Your Rights \u2013 HUMA - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-january-17-2025-to-discuss-your-rights-huma\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-january-17-2025-to-discuss-your-rights-huma\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMzMTEwNCM2NjkxNTczIzIwMjA0MjY=\",\"datePublished\":\"2025-01-13T17:05:32+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-january-17-2025-to-discuss-your-rights-huma\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-january-17-2025-to-discuss-your-rights-huma\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-january-17-2025-to-discuss-your-rights-huma\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMzMTEwNCM2NjkxNTczIzIwMjA0MjY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMzMTEwNCM2NjkxNTczIzIwMjA0MjY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-january-17-2025-to-discuss-your-rights-huma\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Humacyte, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact Levi &amp; Korsinsky Before January 17, 2025 to Discuss Your Rights \u2013 HUMA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Humacyte, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact Levi &amp; Korsinsky Before January 17, 2025 to Discuss Your Rights \u2013 HUMA - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-january-17-2025-to-discuss-your-rights-huma\/","og_locale":"en_US","og_type":"article","og_title":"Humacyte, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact Levi &amp; Korsinsky Before January 17, 2025 to Discuss Your Rights \u2013 HUMA - Market Newsdesk","og_description":"NEW YORK, Jan. 13, 2025 (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in Humacyte, Inc. (&#8220;Humacyte, Inc.&#8221; or the &#8220;Company&#8221;) (NASDAQ: HUMA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Humacyte, Inc. investors who were adversely affected by alleged securities fraud between May 10, 2024 and October 17, 2024. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/humacyte-inc-lawsuit-submission-form?prid=122014&amp;wire=3\u00a0 HUMA investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and\/or concealed that: (1) the Company\u2019s Durham, North Carolina facility failed to comply with &hellip; Continue reading \"Humacyte, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact Levi &amp; Korsinsky Before January 17, 2025 to Discuss Your Rights \u2013 HUMA\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-january-17-2025-to-discuss-your-rights-huma\/","og_site_name":"Market Newsdesk","article_published_time":"2025-01-13T17:05:32+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMzMTEwNCM2NjkxNTczIzIwMjA0MjY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-january-17-2025-to-discuss-your-rights-huma\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-january-17-2025-to-discuss-your-rights-huma\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Humacyte, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact Levi &amp; Korsinsky Before January 17, 2025 to Discuss Your Rights \u2013 HUMA","datePublished":"2025-01-13T17:05:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-january-17-2025-to-discuss-your-rights-huma\/"},"wordCount":408,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-january-17-2025-to-discuss-your-rights-huma\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMzMTEwNCM2NjkxNTczIzIwMjA0MjY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-january-17-2025-to-discuss-your-rights-huma\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-january-17-2025-to-discuss-your-rights-huma\/","name":"Humacyte, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact Levi &amp; Korsinsky Before January 17, 2025 to Discuss Your Rights \u2013 HUMA - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-january-17-2025-to-discuss-your-rights-huma\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-january-17-2025-to-discuss-your-rights-huma\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMzMTEwNCM2NjkxNTczIzIwMjA0MjY=","datePublished":"2025-01-13T17:05:32+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-january-17-2025-to-discuss-your-rights-huma\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-january-17-2025-to-discuss-your-rights-huma\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-january-17-2025-to-discuss-your-rights-huma\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMzMTEwNCM2NjkxNTczIzIwMjA0MjY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMzMTEwNCM2NjkxNTczIzIwMjA0MjY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-january-17-2025-to-discuss-your-rights-huma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Humacyte, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact Levi &amp; Korsinsky Before January 17, 2025 to Discuss Your Rights \u2013 HUMA"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/800112","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=800112"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/800112\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=800112"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=800112"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=800112"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}